Zyma Laboratories Limited
About Zyma Laboratories Limited
Data last updated:
Zyma Laboratories Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 21 November 1970.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1970PLC014881. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹1.66 Cr and a paid-up capital of ₹1.38 Cr. It was led by directors including Sunil Makharia and Nilesh Deshbandhu Gupta.
Its last annual general meeting (AGM) was held on 29 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 159 Cst Road. Kalina Santacruz East, Mumbai, Maharashtra, India – 400098.
As per the financials filed for FY 2016, the company reported a revenue of ₹112.9 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹51.2 Cr (net margin 45.3%) and EBITDA of ₹53.33 Cr (EBITDA margin 47.2%).
Company details
CIN history
Zyma Laboratories has one previous CIN (Corporate Identification Number): U24230MH1970PTC014881. The current CIN is U24230MH1970PLC014881, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1970PLC014881 | Current |
| U24230MH1970PTC014881 | Previous |
Contact details
Zyma Laboratories Limited's registered office is in Mumbai, Maharashtra.
- Registered Address159 Cst Road. Kalina Santacruz East, Mumbai, Maharashtra, India – 400098
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zyma Laboratories Limited
FY 2016 filings availableZyma Laboratories Limited reported revenue of ₹112.9 Cr (up 225% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue rose 225% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹53.33 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹51.2 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 47.2% | |
| Net Profit Margin | 45.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Zyma Laboratories Limited, buy the company report.
Board of directors of Zyma Laboratories Limited
Zyma Laboratories has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Makharia Also directs: Lupin Manufacturing Solutions Limited, Polynova Industries Limited, Lupin Investments Private Limited and 3 more | Director | 14 Jun 2012 | 14 Years 4 Months | As last reported |
| Nilesh Deshbandhu Gupta Also directs: Lupin Manufacturing Solutions Limited, Polynova Industries Limited, Lupin Investments Private Limited and 5 more | Director | 24 Jun 2004 | 22 Years 4 Months | As last reported |
| Manju Deshbandhu Gupta Also directs: Lupin Manufacturing Solutions Limited, Polynova Industries Limited, Lupin Limited and 2 more | Director | 16 Feb 1976 | 50 Years 8 Months | As last reported |
Peer comparison
Zyma Laboratories Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Broking Services), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Qcap Securities Private Limited | ₹114.5 Cr (FY 2024) | -26.0% | Mumbai, Maharashtra, India | |||
| Asian Markets Securities Private Limited | ₹113.69 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Gateway Financial Services Ltd | ₹113.55 Cr (FY 2025) | -8.0% | Kolkata, West Bengal, India | |||
| K.P.R. Developers Limited | ₹113.34 Cr (FY 2025) | -58.0% | Coimbatore, Tamil Nadu, India | |||
| Twentyfirst Century Management Services Limited | ₹112.95 Cr (FY 2025) | 193.0% | Chennai, Tamil Nadu, India | |||
| Zyma Laboratories Limitedthis company | ₹112.9 Cr (FY 2016) | ₹51.2 Cr | 45.3% | 225.0% | Mumbai, Maharashtra, India | |
| Pneumatic Services Private Limited | ₹112.68 Cr (FY 2025) | -32.0% | New Delhi, Delhi, India | |||
| Irage Broking Services LLP | ₹112.41 Cr (FY 2023) | 12.0% | Gandhinagar, Gujarat, India | |||
| Devaashish Comtrade Private Limited | ₹112.13 Cr (FY 2025) | 3396.0% | Jodhpur, Rajasthan, India | |||
| Expertpro Realty Private Limited | ₹112.03 Cr (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Anantnath Skycon Private Limited | ₹111.67 Cr (FY 2025) | 22.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Zyma Laboratories Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zyma Laboratories Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zyma Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zyma Laboratories has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Zyma Laboratories Limited, buy the company report.
Recent activity
Zyma Laboratories Limited has 7 board changes on record since 1976: 3 appointments and 4 cessations. The latest: Desh Bandhu Gupta ceased to be Director on 26 Jun 2017.
Frequently asked questions
Zyma Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Zyma Laboratories was a public limited company based in Mumbai, Maharashtra, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 21 November 1970 and is registered under CIN U24230MH1970PLC014881. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Zyma Laboratories was incorporated on 21 November 1970. It is registered with the Registrar of Companies, Mumbai.
Zyma Laboratories had 3 directors:
- Sunil Makharia - Director
- Nilesh Deshbandhu Gupta - Director
- Manju Deshbandhu Gupta - Director
The CIN (Corporate Identification Number) of Zyma Laboratories is U24230MH1970PLC014881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Zyma Laboratories is at 159 Cst Road. Kalina Santacruz East, Mumbai, Maharashtra, India – 400098.
The latest financial statements of Zyma Laboratories on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 29 September 2016. Year-wise statements from 2015 are in the company report.
No. Zyma Laboratories has 2 GST registrations on record and all of them are cancelled or inactive.
Zyma Laboratories operated in the chemicals industry, in the other chemical product segment.
The peers of Zyma Laboratories by revenue are Qcap Securities Private Limited, Asian Markets Securities Private Limited, Gateway Financial Services Ltd, K.P.R. Developers Limited, Twentyfirst Century Management Services Limited and 5 more, all in the BFSI industry (Broking Services).
Desh Bandhu Gupta ceased to be Director on 26 Jun 2017. Sunil Makharia ceased to be Additional Director on 28 Sep 2012. Sunil Makharia was appointed as Director on 14 Jun 2012. Zyma Laboratories has 7 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
